[go: up one dir, main page]

DE60126504D1 - Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa - Google Patents

Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa

Info

Publication number
DE60126504D1
DE60126504D1 DE60126504T DE60126504T DE60126504D1 DE 60126504 D1 DE60126504 D1 DE 60126504D1 DE 60126504 T DE60126504 T DE 60126504T DE 60126504 T DE60126504 T DE 60126504T DE 60126504 D1 DE60126504 D1 DE 60126504D1
Authority
DE
Germany
Prior art keywords
oral
treatment
intestinal mucosa
disorders
candida
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60126504T
Other languages
English (en)
Other versions
DE60126504T2 (de
Inventor
Giancarla Dondi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Proge Farm Srl
Original Assignee
Proge Farm Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Proge Farm Srl filed Critical Proge Farm Srl
Publication of DE60126504D1 publication Critical patent/DE60126504D1/de
Application granted granted Critical
Publication of DE60126504T2 publication Critical patent/DE60126504T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE60126504T 2000-11-02 2001-10-29 Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa Expired - Lifetime DE60126504T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI20002369 2000-11-02
IT2000MI002369A IT1320772B1 (it) 2000-11-02 2000-11-02 Composizione farmaceutica a base di agenti attivi contro la candidaper il trattamento di disturbi della mucosa orale e intestinale
PCT/IB2001/002036 WO2002036137A1 (en) 2000-11-02 2001-10-29 Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa

Publications (2)

Publication Number Publication Date
DE60126504D1 true DE60126504D1 (de) 2007-03-22
DE60126504T2 DE60126504T2 (de) 2007-11-22

Family

ID=11446081

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60126504T Expired - Lifetime DE60126504T2 (de) 2000-11-02 2001-10-29 Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa

Country Status (7)

Country Link
US (1) US20040043011A1 (de)
EP (1) EP1339419B1 (de)
AT (1) ATE353221T1 (de)
AU (1) AU2001295839A1 (de)
DE (1) DE60126504T2 (de)
IT (1) IT1320772B1 (de)
WO (1) WO2002036137A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1384483A1 (de) 2002-07-23 2004-01-28 Nestec S.A. Probiotische Mikroorganismen zur Behandlung von Colon Irritabile durch die Verbesserung der neuromuskulären Darmfunktion

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6855M (de) * 1967-12-18 1969-04-08
US4839281A (en) * 1985-04-17 1989-06-13 New England Medical Center Hospitals, Inc. Lactobacillus strains and methods of selection
ZA935111B (en) * 1992-07-17 1994-02-04 Smithkline Beecham Corp Rapamycin derivatives
GB9302567D0 (en) * 1993-02-10 1993-03-24 Smithkline Beecham Plc Novel compound
IT1299070B1 (it) * 1998-04-10 2000-02-07 Proge Farm Srl Ceppi di lattobacilli capaci di inibire e/o avere azione microbicida nei confronti di microorganismi patogeni e metodo di induzione e
EP0904784A1 (de) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
US5981499A (en) * 1998-02-20 1999-11-09 Atlantic Biomed Corporation Lesion-directed antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius

Also Published As

Publication number Publication date
ITMI20002369A1 (it) 2002-05-02
IT1320772B1 (it) 2003-12-10
DE60126504T2 (de) 2007-11-22
EP1339419A1 (de) 2003-09-03
ATE353221T1 (de) 2007-02-15
AU2001295839A1 (en) 2002-05-15
WO2002036137A1 (en) 2002-05-10
EP1339419B1 (de) 2007-02-07
US20040043011A1 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
HUP0301868A2 (hu) Gyógyászati készítmény, ami VIIa és XIII-as faktort tartalmaz
DE60126980D1 (de) Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen
NO20050851L (no) Kaspase-inhibitorer og anvendelser derav
ATE399553T1 (de) Pharmazeutische zusammensetzungen mit dextromethorphan und chinidin zur behandlung von neurologischen erkrankungen
GB0025173D0 (en) Therapeutic agents
NO20053855D0 (no) 1-fenylalkankarboksylsyrederivater til behandling av neurodegenerative sykdommer.
EE05423B1 (et) IL-18 inhibiitori kasutamine maksakahjustuse ja muude haiguste raviks v?i ennetamiseks sobiva ravimi valmistamiseks, vektori ja raku kasutamine inhibiitori produtseerimisel ning IL-18 inhibiitorit sisaldav farmatseutiline kompositsioon
BG105302A (en) Means for improving cognition
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
BR0014355A (pt) Derivados de sapogenina e seu uso no tratamento de disfunção cognitiva
ATE303817T1 (de) Verwendung von osteoprotegerin zur vorbeugung und behandlung cardiovaskulärer erkrankungen
TW200633978A (en) 2,3,4,9-tetrahydro-1H-carbazole derivatives as crth2 receptor antagonists
ATE400277T1 (de) Pharmazeutische zusammenstellung zur vorbeugung und behandlung von mit zellkrankheiten des augenhintergrundes zusammenhängenden krankheiten
SE0001916D0 (sv) Novel formulation
RS60604A (en) Carboxamidine derivatives and their use in the treatment of vascular diseases
DE60142786D1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
DE60126504D1 (de) Verwendung von gegen candida wirksamen mitteln zur behandlung von störungen der oralen und intestinalen mucosa
ATE314064T1 (de) L-acetylcarnitin und l-propionylcarnitin zusammensetzung zur verhütung und behandlung von nierenstörungen und nierenenkrankheit
DE60306503D1 (de) Statin-therapie zur verbesserung der aufrechterhaltung der kognitiven funktion
BR0005319A (pt) Tratamento combinado para depressão e ansiedade
DE60117541D1 (de) Candesartan zur Behandlung von Migräne
DE60212349D1 (de) Verwendung von n-acetyl-d-glucosamin bei der herstellung eines pharmazeutischen mittels zur prävention und behandlung von sexuellen störungen
ATE407925T1 (de) 1,4-dihydropyridinverbindungen, pharmazeutische verbindungen, und verfahren zur behandlung von herzkreislauferkrankungen
TR199901385T2 (xx) Piperidin t�revleri.
HUP0102116A2 (hu) Paroxetin-aszkorbát, eljárás az előállítására és gyógyászati alkalmazása

Legal Events

Date Code Title Description
8364 No opposition during term of opposition